FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines

(2015) Jiri Sana et al.   Analytical Cellular Pathology

Cellular Heterogeneity and Molecular Evolution in Cancer

(2012) Vanessa Almendro et al.   Annual Review of Pathology-Mechanisms of Disease

FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma

(2012) L. E. S. Crose et al.   CLINICAL CANCER RESEARCH

BH3-only proteins in apoptosis at a glance

(2012) L. Happo et al.   JOURNAL OF CELL SCIENCE

CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV

(2012) Joseph G. Pressey et al.   PEDIATRIC BLOOD & CANCER

ERK2 phosphorylation of serine 77 regulates Bmf pro-apoptotic activity

(2012) Y Shao et al.   Cell Death & Disease

High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis

(2011) Vera Paulson et al.   GENES CHROMOSOMES & CANCER

FOXO1–FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma

(2011) Jinglan Liu et al.   MODERN PATHOLOGY

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres

(2011) Dagmar Walter et al.   PLoS One

Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer

(2010) L. Cao et al.   CANCER RESEARCH

Use of molecular markers for predicting therapy response in cancer patients

(2010) Michael J. Duffy et al.   CANCER TREATMENT REVIEWS

Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM

(2010) Ceri M. Wiggins et al.   CELLULAR SIGNALLING

Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

(2010) Daniel Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

(2009) Simona Ognjanovic et al.   CANCER

The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

(2009) R. T. Kurmasheva et al.   CANCER RESEARCH

Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2β as biomarkers for rhabdomyosarcoma diagnostics

(2009) Beate Grass et al.   HISTOPATHOLOGY

Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma

(2009) S. Oesch et al.   MOLECULAR CANCER THERAPEUTICS

The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis

(2008) Andrew H Sims et al.   BMC Medical Genomics

Phosphorylation Regulates Transcriptional Activity of PAX3/FKHR and Reveals Novel Therapeutic Possibilities

(2008) R. Amstutz et al.   CANCER RESEARCH

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY